NOTE: The following is a list of district swimming and diving qualifiers from News-Herald coverage area schools only. There is no sectional diving, so all divers advance straight to district. With ...

Dr. Saef Izzy, Associate Professor of Neurology at ... such as Multiple Sclerosis (MS), Alzheimer’s disease, ALS, and Parkinson's disease. Tiziana has also broadened its Phase 2 trial for ...

And some researchers hoped that the drugs could also help with some of the most difficult diseases to treat — those of the brain, like Parkinson’s. But now, at least for Parkinson’s ...

x.com Tweets by stylebender Tweets by imavov1 Tweets by stylebender x.com x.com Some great takedown defense by Izzy so far. Impressive.

Get Instant Summarized Text (Gist) A key regulator for the GTPase function of the LRRK2 gene, linked to Parkinson's Disease, has been identified. This regulator, CalDAG-GEFI, can control the ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease. The US FDA this week approved the sale of the treatment, which ...

The University of Tasmania will today launch a free Massive Open Online Course (MOOC) on Parkinson's Disease. The course — developed by the University's Wicking Dementia Research and Education ...

It’s a family affair as Israel “Izzy” Battres returns to HGTV for the new docuseries Izzy Does It. Cameras follow the former Flip or Flop contractor while running his renovation business in ...

He was soon diagnosed with Parkinson’s disease, a degenerative neurological disorder that affects motor functions and causes cognitive impairment, despite having no family history or genetic ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

The act establishes a Federal Advisory Council on Parkinson's Research, Care, and Services and calls for the creation and regular updating of a national plan to prevent, diagnose, treat ...

Treatment with the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide had no disease-modifying effects on movement, symptom severity or brain imaging in patients with Parkinson’s disease ...